Dr. Hongling Wang is a physician in the Department of Head & Neck Surgery, Tianjin Medical University Cancer Institute & Hospital. Her clinical practice and research are dedicated to the multimodal management of head and neck cancer, with a special focus on locally advanced hypopharyngeal cancer, organ-preserving strategies, and minimally-invasive therapy. She participates in clinical trials investigating neoadjuvant immunochemotherapy for head and neck cancers. She has authored multiple peer-reviewed publications and actively engages in international academic exchanges to optimize patient treatment outcomes.